Eisai
4523.T
#1927
Rank
โ‚น714.92 B
Marketcap
โ‚น2,536
Share price
0.67%
Change (1 day)
-41.59%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Revenue for Eisai (4523.T)

Revenue in 2024 (TTM): โ‚น419.75 Billion

According to Eisai's latest financial reports the company's current revenue (TTM ) is โ‚น427.11 Billion. In 2023 the company made a revenue of โ‚น440.39 Billion a decrease over the revenue in the year 2022 that were of โ‚น459.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eisai from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น419.75 B-4.69%
2023 โ‚น440.39 B-4.18%
2022 โ‚น459.61 B-2.94%
2021 โ‚น473.52 B-2.93%
2020 โ‚น487.81 B12.8%
2019 โ‚น432.45 B8.64%
2018 โ‚น398.07 B22.86%
2017 โ‚น324.00 B-3.09%
2016 โ‚น334.34 B7.24%
2015 โ‚น311.77 B-5.44%
2014 โ‚น329.72 B-10.09%
2013 โ‚น366.71 B-4.98%
2012 โ‚น385.93 B-12.37%
2011 โ‚น440.43 B4.66%
2010 โ‚น420.83 B8.57%
2009 โ‚น387.61 B